1. Home
  2. QTRX vs CHPT Comparison

QTRX vs CHPT Comparison

Compare QTRX & CHPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTRX
  • CHPT
  • Stock Information
  • Founded
  • QTRX 2007
  • CHPT 2007
  • Country
  • QTRX United States
  • CHPT United States
  • Employees
  • QTRX N/A
  • CHPT N/A
  • Industry
  • QTRX Biotechnology: Laboratory Analytical Instruments
  • CHPT Industrial Specialties
  • Sector
  • QTRX Industrials
  • CHPT Consumer Discretionary
  • Exchange
  • QTRX Nasdaq
  • CHPT Nasdaq
  • Market Cap
  • QTRX 439.1M
  • CHPT 483.4M
  • IPO Year
  • QTRX 2017
  • CHPT N/A
  • Fundamental
  • Price
  • QTRX $10.50
  • CHPT $1.24
  • Analyst Decision
  • QTRX Strong Buy
  • CHPT Hold
  • Analyst Count
  • QTRX 4
  • CHPT 13
  • Target Price
  • QTRX $23.25
  • CHPT $2.51
  • AVG Volume (30 Days)
  • QTRX 375.4K
  • CHPT 18.6M
  • Earning Date
  • QTRX 11-12-2024
  • CHPT 12-04-2024
  • Dividend Yield
  • QTRX N/A
  • CHPT N/A
  • EPS Growth
  • QTRX N/A
  • CHPT N/A
  • EPS
  • QTRX N/A
  • CHPT N/A
  • Revenue
  • QTRX $129,330,000.00
  • CHPT $431,026,000.00
  • Revenue This Year
  • QTRX $13.89
  • CHPT N/A
  • Revenue Next Year
  • QTRX $15.51
  • CHPT $15.02
  • P/E Ratio
  • QTRX N/A
  • CHPT N/A
  • Revenue Growth
  • QTRX 15.52
  • CHPT N/A
  • 52 Week Low
  • QTRX $9.87
  • CHPT $1.05
  • 52 Week High
  • QTRX $29.70
  • CHPT $2.68
  • Technical
  • Relative Strength Index (RSI)
  • QTRX 40.42
  • CHPT 51.77
  • Support Level
  • QTRX $10.29
  • CHPT $1.13
  • Resistance Level
  • QTRX $11.51
  • CHPT $1.30
  • Average True Range (ATR)
  • QTRX 0.80
  • CHPT 0.11
  • MACD
  • QTRX -0.13
  • CHPT -0.00
  • Stochastic Oscillator
  • QTRX 20.10
  • CHPT 32.05

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.

About CHPT ChargePoint Holdings Inc.

ChargePoint designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.

Share on Social Networks: